Paras Healthcare IPO Allotment Status: Steps to Verify Status & Key Issue Details

26 October 2026
3 min read
Paras Healthcare IPO Allotment Status: Steps to Verify Status & Key Issue Details
whatsapp
facebook
twitter
linkedin
telegram
copyToClipboard

Investors who subscribed to the ₹1,450.00 crore Paras Healthcare IPO can expect the share allotment to be finalised on October 26, 2026. The allotment details can be accessed online through the NSE and BSE websites or via the IPO registrar, MUFG Intime India Private Limited.

Once the allotment is concluded, Paras Healthcare is scheduled to make its stock market debut on October 28, 2026, on both the NSE and BSE.

Procedure to Check Paras Healthcare IPO Allotment Status Online on NSE

  • Visit the NSE’s IPO allotment verification status page here.
  • Select “Equity & SME IPO Bid Details”.
  • In Select, choose “PARASHLTH”.
  • Enter your PAN No. and Application No.
  • Click “Submit”.

Procedure to Check Paras Healthcare IPO Allotment Status Online on BSE

  • Click here to visit the application status page. 
  • Under Issue Type, select “Equity”.
  • In Issue Name, select “Paras Healthcare Limited”.
  • Enter your “Application No. or PAN No.”
  • Enter the given Captcha correctly.
  • Click “Submit”.

Procedure to Check Paras Healthcare IPO Allotment Status on MUFG Intime India (Registrar to the issue)

  • Visit MUFG Intime India’s IPO allotment status page here.
  • In the “Select company”, choose “Paras Healthcare Limited”.
  • Enter any of the following details:
    • PAN
    • App. No.
    • DP/Client ID
    • Account No/ IFSC
  • Click “Submit”.

Paras Healthcare IPO - Issue Details

  • Issue Type: Book Built Issue (Fresh Issue + OFS)
  • Total Issue Size: Up to ₹1,450.00 crore
  • Fresh Issue: Up to ₹500.00 crore
  • Offer for Sale (OFS): Up to ₹950.00 crore
  • Face Value: ₹1 per equity share
  • Price Band: ₹660 to ₹693 per share
  • Lot Size: 21 shares
  • Minimum Investment Amount (Retail Investor): ₹14,553 (21 shares at the upper price)
  • Listing: BSE, NSE
  • Book Running Lead Managers: JM Financial Limited, BofA Securities India Limited, Nuvama Wealth Management Limited
  • Registrar: MUFG Intime India Private Limited

Explore other Upcoming IPOs on BSE and NSE.

Paras Healthcare IPO Overall Subscription Status

[October 23, 2026, 7:00 P.M.]

Category 

Subscription (x)

Qualified Institutional Buyers (QIBs)

3.09x

Non-Institutional Investors (NIIs)

0.66x

Retail Individual Investors (RIIs)

2.00x

Employees

23.61x

Total 

2.23x

Utilisation of IPO Proceeds

The company intends to utilise the net proceeds from the fresh issue towards:

  • Prepayment or scheduled re-payment, in full or part, of certain outstanding borrowings availed by the company 
  • Investment in its wholly owned Subsidiary, PMHPL (which also operates the company’s hospital in Srinagar), for repayment/prepayment of borrowings, in full or part, of PMHPL 
  • General corporate purposes

About Paras Healthcare Limited

Incorporated in 1987, Paras Healthcare Limited is a healthcare provider operating eight hospitals with a combined capacity of 2,211 beds across North India, Bihar and Jharkhand, under the “Paras Health” brand. As of June 30, 2026, its network spanned five states and one union territory.

The company plans to add 300 beds in Gurugram by Fiscal 2027 and 500 beds in Ludhiana by Fiscal 2028, taking its total capacity to 3,011 beds by March 2028. Its key specialties include cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics and renal sciences, which contributed 74.70% of revenue in Fiscal 2026. The company had 1,084 doctors and 1,937 nurses as of June 30, 2026.

Key Financial Highlights 

Particulars

For the three month period ended June 30, 2026 (in ₹ crore)

FY26

(in ₹ crore)

FY25

(in ₹ crore)

Revenue from operations

470.28

1,605.95 

1,294.06

EBITDA

113.48

335.58 

156.46

Profit After Tax (PAT)

49.68

43.83 

(57.98)

Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.   

To read the RA disclaimer, please click here

Do you like this edition?